As a result of 6 phase 2 trials, the FDA has designated MDMA-assisted psychotherapy for PTSD as breakthrough therapy.
These data may be useful in developing care strategies for mothers suffering from stress exposure and in predicting the temperaments of their children.
Significant reductions in all symptom scores after intervention in military personnel.
Cognitive processing therapy was directly compared with written exposure therapy for individuals with PTSD.
Individuals with chronic pain and PTSD have poor pain-related outcomes.
Mean reductions in Clinician-Administered PTSD Scale scores from baseline were significantly greater in the propranolol group compared with the placebo group.
Prolonged exposure therapy was associated with a greater reduction in PTSD symptom severity compared with a minimal-contact control.
Catatstrophic thinking about pain in children may mediate the relationship between chronic pain and PTSD.
In the military trauma setting, ketamine administration is not linked with PTSD.
The FDA has granted Breakthrough Therapy Designation to MDMA for treating PTSD.
Psychiatry Advisor Articles
- Sertraline Effective for Treating Depression in Vascular Cognitive Impairment
- Hospitalization Rates in Schizophrenia—Lurasidone vs Quetiapine
- Ketamine-Induced Dissociative Symptoms Predict Antidepressant Response
- First Nonopioid Drug Approved for Managing Opioid Withdrawal Symptoms
- Review Examines the Effectiveness of Antidepressants for Insomnia
- Video Games and Exercise as Alternative Therapies for ADHD
- How Parents Can Enhance Autism Treatment: Use of Intervention Strategies at Home
- Electroconvulsive Therapy Effective in Children With Autism
- Comorbid Autism Spectrum Disorder and OCD: Challenges in Diagnosis and Treatment
- The Cutting Edge of Schizophrenia Research: VR as Treatment for Psychosis
- Antidepressant Use May Be Linked With Sustained Risk for Weight Gain
- Language Used in Medical Record Can Affect Patient Care
- Family History of Psychiatric Disorders an Important Predictor of Postpartum Psychiatric Illness
- Increased Risk for Type 2 Diabetes in Adolescents, Young Adults With ADHD
- Worse Cognitive Outcomes Associated With CMV Antibodies Following ART for HIV